Impact BioMedical IBO Stock Slides 151 Support at 054 20260514 CrossTimbers CRT Stock Down 125 Support Test at 1012 20260514 Creator Content Takes Center Stage at TV Upfronts as Media Giants Court Younger Audiences Bank of NTB Jumps 236 on Strong Momentum 20260518 EU Weighs Merkel or Draghi as Potential Special Envoy for Ukraine Talks Aldeyra ALDX Crushes Q1 2026 Estimates EPS 006 Tops Views TCW TSI Unchanged at 451 RangeBound Trading 20260520 Orla Mining Holds Steady Near Resistance as Gold Sector Sentiment Remains Mixed Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Among Key Investor Topics in CNBC Morning Squawk Love Factually Dating StartUps Promise to Cut the Cheats A New Market Niche Emerges Most Undervalued Major Cryptos Heading Into Mid2026 BP Chairman Removed Amid Allegations of Bullying and Overbearing Conduct Wolfe Research Names Amazon AMZN a Top Pick in the Internet Sector Delivery Hero Reveals 10bn Takeover Bid from Uber Also Approached by DoorDash PGEN Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Zero Revenue JBI Q1 2026 Earnings EPS Misses Estimates Amid Revenue Disclosure Absence HBIO Q1 2026 Earnings Loss Narrower Than Expected on Cost Controls Pangaea Logistics Solutions Ltd PANL Q1 2026 Earnings EPS Beats Estimates by 204 Amid Cautious Market Response Inhibikase Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss but Stock Declines Applied Digital Reports Fiscal Third Quarter 2026 Results AI Infrastructure Demand in Focus CHEF Q1 2026 Earnings Strong EPS Beat Drives Positive Sentiment AAP Q1 2026 Earnings EPS Surges Past Expectations Amid Challenging Retail Environment STRD Q1 2026 Earnings Preferred Stock Posts Significant EPS Miss Surprise 77041 Wetouch Technology Inc Q1 1996 Earnings EPS Falls Short of Estimates Stock Rises on Speculative Optimism AMPY Q1 2026 Earnings Significant EPS Miss Highlights Operational Challenges Ellington Credit Company Q1 2026 Earnings EPS Miss Amidst Mixed Credit Markets EVGN Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Spend ADM Q1 2026 Earnings EPS Beats Estimates Amid Cautious Market Environment